Abstract
Nanotechnology plays a key role in the development of new drugs, from
start to end through target identification, lead identification, lead optimization, and
synthesis of active pharmaceutical ingredients (API) as well. Nanodevices and
nanoparticles have been extensively utilized in discovering new drug targets in illness
sites or blood and for swift screening of interactions of molecular compounds with
therapeutic targets for lead identification/optimization. In addition, API development
employing nanoparticle catalysts to expedite the drug development process and
investigating pure nanomaterials as drugs are two further areas on which the
pharmaceutical industry is concentrating. This chapter will go into great detail on how
nanotechnology is used in the drug development process, starting with the
identification of drug targets, moving on to the identification and optimization of leads,
and concluding with the synthesis of API.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Drug Delivery Letters
Recent Advances in Anti-Infective Drug Discovery
Applied Drug Research, Clinical Trials and Regulatory Affairs
Current Bioactive Compounds
Current Drug Delivery
Current Drug Safety
Drug Metabolism and Bioanalysis Letters
Recent Advances in Drug Delivery and Formulation
Reviews on Recent Clinical Trials
Related Books
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Biotechnology and Drug Development for Targeting Human Diseases
4th International Conference on Drug Discovery and Therapy - 2012
Applied Computer-Aided Drug Design: Models and Methods
Computational Toxicology for Drug Safety and a Sustainable Environment
AI Innovations in Drug Delivery and Pharmaceutical Sciences; Advancing Therapy through Technology
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development